BioHealth News Archive
TEDCO’s Maryland Innovation Initiative (MII) Announces Recent Investments
$2.1M invested in seven companies to advance innovations from lab to market in Maryland COLUMBIA, Md. (August 13, 2024) — TEDCO, Maryland’s economic engine…
Read More
United Therapeutics to Build Medical Transplant Center in Minnesota
Multi-billion-dollar US-based biotech firm United Therapeutics has announced that it has purchased 32 acres (13 hectares) of land in Minnesota, US, for US$4.5 million…
Read More
Linshom Medical Completes Clinical Study Enrollment at The Ohio State University Wexner Medical Center
BALTIMORE, MARYLAND, US, August 12, 2024 /EINPresswire.com/ -- The study, “Advanced Prediction of Respiratory Depression Episodes with the Linshom Continuous Predictive Respiratory Sensor”, completed…
Read More
Innovating Preclinical Models: Mimetas Leads the Way in Organ Design
In a recent article by Genetic Engineering & Biotechnology News, Paul Vulto, PhD, CEO of Mimetas, discusses the growing demand for advanced organ modeling…
Read More
One Month Countdown: BioHealth Capital Region Week is Nearly Here!
We’re just over a month away from the 2024 BioHealth Capital Region Week, which takes place from September 17th, 18th, and 19th at US Pharmacopeia…
Read More
Baltimore’s Neurotech Innovation Achieves Patent Approval and Featured Cover Story in Prominent Industry Journal
(Baltimore, MD) - Longeviti Neuro Solutions, a neurotechnology company with a focus on innovative solutions for complex brain surgeries, proudly announces the issuance of…
Read More
Cellphire Therapeutics announces the addition of Dr. Damien Bates as Chief Medical Officer and transition of Allan Alexander, our current CMO to an advisory role.
Rockville, Md. (August 5, 2024) – Cellphire Therapeutics, Inc., a clinical stage biotechnology company developing next-generation allogeneic cellular therapeutics, announced today that Damien Bates,…
Read More
Maximizing Investment Opportunities at the BioHealth Capital Region Investment Conference
The 7th Annual Investment Conference, scheduled for September 19th during the BioHealth Capital Region Week at US Pharmacopeia in Rockville, MD, offers a unique…
Read More
Emergent BioSolutions Expands NARCAN® Nasal Spray Distribution Capabilities to Enhance Customer Delivery Experience Across the Country
GAITHERSBURG, Md., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced the introduction of a new NARCANDirect™ distribution center in Nevada to further demonstrate its commitment to broadening…
Read More
PMLIVE: GSK and Flagship Pioneering partner in deal worth up to $7bn to discover medicines and vaccines
GSK and Flagship Pioneering have entered into a partnership worth up to $7bn to discover and develop novel medicines and vaccines for a range…
Read More
Theriva™ Biologics Receives Rare Pediatric Drug Designation by the U.S. FDA for VCN-01 for the Treatment of Retinoblastoma
ROCKVILLE, Md., July 31, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics, Inc. (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer…
Read More
Sirnaomics Announces a Partnership with Gore Range Capital for Establishment of a JV, Sagesse Bio, to Advance Its RNAi Therapeutics into Aesthetic Medicine
HONG KONG, GERMANTOWN, Md. and SUZHOU, China, July 31, 2024 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company engaging…
Read More
BullFrog AI and Lieber Institute for Brain Development Reveal New Insights into Bipolar Disorder Pathways and Potential Drug Targets
GAITHERSBURG, Md., July 25, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a leader in AI-driven…
Read More
Georgiamune Announces First Patient Dosed in A First-In-Class Phase 1 Cancer Treatment Trial of GIM-531
GAITHERSBURG, Md., July 30, 2024 (GLOBE NEWSWIRE) -- Today, Georgiamune Inc., a privately held, clinical-stage biotechnology company, announced that the first patient has been dosed…
Read More
Emergent BioSolutions Completes Sale of RSDL® (Reactive Skin Decontamination Lotion) Kit to SERB Pharmaceuticals for $75 Million
GAITHERSBURG, Md., July 31, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced the sale of RSDL® (Reactive Skin Decontamination Lotion) kit to SERB…
Read More